Cambridge Investment Research Advisors’s National Health Investors NHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$532K Sell
6,982
-2,214
-24% -$170K ﹤0.01% 2901
2026
Q1
$744K Buy
9,196
+201
+2% +$16.7K ﹤0.01% 2434
2025
Q4
$687K Buy
8,995
+139
+2% +$10.7K ﹤0.01% 2429
2025
Q3
$704K Buy
8,856
+336
+4% +$25.1K ﹤0.01% 2343
2025
Q2
$597K Buy
8,520
+1,159
+16% +$84.9K ﹤0.01% 2382
2025
Q1
$544K Sell
7,361
-565
-7% -$39.8K ﹤0.01% 2358
2024
Q4
$549K Sell
7,926
-830
-9% -$63.1K ﹤0.01% 2351
2024
Q3
$736K Sell
8,756
-505
-5% -$38.9K ﹤0.01% 2099
2024
Q2
$627K Sell
9,261
-426
-4% -$27.3K ﹤0.01% 2110
2024
Q1
$609K Buy
9,687
+2,227
+30% +$126K ﹤0.01% 2106
2023
Q4
$417K Buy
7,460
+447
+6% +$23.7K ﹤0.01% 2340
2023
Q3
$360K Sell
7,013
-336
-5% -$17.6K ﹤0.01% 2361
2023
Q2
$385K Sell
7,349
-516
-7% -$26.6K ﹤0.01% 2334
2023
Q1
$406K Buy
7,865
+243
+3% +$13.3K ﹤0.01% 2243
2022
Q4
$398K Sell
7,622
-564
-7% -$30.9K ﹤0.01% 2204
2022
Q3
$463K Buy
8,186
+341
+4% +$21.5K ﹤0.01% 1996
2022
Q2
$476K Buy
7,845
+229
+3% +$13K ﹤0.01% 2001
2022
Q1
$449K Buy
7,616
+13
+0.2% +$740 ﹤0.01% 2200
2021
Q4
$437K Buy
7,603
+789
+12% +$43.7K ﹤0.01% 2218
2021
Q3
$365K Sell
6,814
-463
-6% -$28.9K ﹤0.01% 2294
2021
Q2
$488K Sell
7,277
-902
-11% -$62.9K ﹤0.01% 2082
2021
Q1
$591K Buy
8,179
+778
+11% +$54.3K ﹤0.01% 1778
2020
Q4
$512K Sell
7,401
-422
-5% -$26.8K ﹤0.01% 1757
2020
Q3
$472K Sell
7,823
-1,282
-14% -$79.1K ﹤0.01% 1641
2020
Q2
$553K Sell
9,105
-1,166
-11% -$64.1K ﹤0.01% 1496
2020
Q1
$509K Buy
10,271
+1,739
+20% +$132K ﹤0.01% 1357
2019
Q4
$695K Buy
8,532
+286
+3% +$23.4K 0.01% 1361
2019
Q3
$679K Sell
8,246
-306
-4% -$24.9K 0.01% 1301
2019
Q2
$667K Buy
8,552
+605
+8% +$47K 0.01% 1257
2019
Q1
$624K Buy
7,947
+507
+7% +$40.3K 0.01% 1334
2018
Q4
$562K Buy
7,440
+50
+0.7% +$3.77K 0.01% 1245
2018
Q3
$559K Buy
7,390
+1,395
+23% +$107K 0.01% 1375
2018
Q2
$442K Sell
5,995
-119
-2% -$8.41K ﹤0.01% 1469
2018
Q1
$411K Sell
6,114
-595
-9% -$40.7K ﹤0.01% 1451
2017
Q4
$506K Buy
6,709
+666
+11% +$51.7K 0.01% 1319
2017
Q3
$467K Buy
6,043
+238
+4% +$18.6K 0.01% 1280
2017
Q2
$460K Sell
5,805
-156
-3% -$11.8K 0.01% 1252
2017
Q1
$433K Buy
5,961
+365
+7% +$26.8K 0.01% 1149
2016
Q4
$415K Sell
5,596
-127
-2% -$9.32K 0.01% 1108
2016
Q3
$449K Sell
5,723
-72
-1% -$5.66K 0.01% 1096
2016
Q2
$435K Buy
5,795
+623
+12% +$43.2K 0.01% 997
2016
Q1
$344K Buy
5,172
+706
+16% +$43.6K 0.01% 1101
2015
Q4
$272K Buy
4,466
+544
+14% +$32.4K 0.01% 1175
2015
Q3
$225K Buy
3,922
+1
+0% +$60 0.01% 1192
2015
Q2
$244K Buy
3,921
+823
+27% +$55K 0.01% 1163
2015
Q1
$220K Buy
+3,098
New +$224K 0.01% 1196

Other funds holding NHI

Cambridge Investment Research Advisors's NHI Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its National Health Investors (NHI) stake by 24% in Q2 2026, selling an estimated $170K and leaving 6,982 shares worth $532K. The position accounts for ﹤0.01% of the portfolio, ranked #2901.

Cambridge Investment Research Advisors first reported a position in NHI in Q1 2015 and has held it in 46 quarters since. The position peaked at $744K in Q1 2026. 82 funds tracked by Wall St. Rank hold NHI as of Q2 2026.

  • Cambridge Investment Research Advisors held 6,982 shares of National Health Investors worth $532K as of Q2 2026.
  • Cambridge Investment Research Advisors sold 2,214 National Health Investors shares in Q2 2026, an estimated $170K.
  • National Health Investors made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #2901 holding.
  • Cambridge Investment Research Advisors first reported a position in National Health Investors in Q1 2015 and has held it in 46 quarters since.
  • Cambridge Investment Research Advisors's National Health Investors position peaked at $744K in Q1 2026.
  • 82 funds tracked by Wall St. Rank held National Health Investors as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.